Lara Longpre

Entity
Individual
Business address
C/O Mirum Pharmaceuticals, Inc., 950 Tower Lane, Suite 1050, 94404 Foster City, CA
Signature Ownership
/s/ Judit Ryvkin, Attorney-in-Fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Lara Longpre has filed 20 SEC EDGAR filings since 7/17/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
144 Open Document Open Filing Jul 1, 2024
4 Open Document Open Filing Mar 18, 2024 Sep 10, 2019 001-38981
4 Open Document Open Filing Feb 5, 2024 Feb 2, 2024 001-38981
4 Open Document Open Filing Jan 25, 2024 Jan 23, 2024 001-38981
4 Open Document Open Filing Jan 9, 2024 Jan 8, 2024 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Nov 15, 2023 Nov 10, 2023 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Jul 5, 2023 Jul 3, 2023 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION May 19, 2023 May 10, 2023 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Feb 2, 2023 Jan 31, 2023 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Nov 14, 2022 Nov 10, 2022 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION May 12, 2022 May 10, 2022 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Jan 7, 2022 Jan 6, 2022 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Nov 15, 2021 Nov 10, 2021 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Oct 1, 2021 Sep 29, 2021 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION May 12, 2021 May 10, 2021 001-38981
4/A Open Document Open Filing FORM 4/A SUBMISSION Mar 8, 2021 Jan 7, 2021 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Jan 11, 2021 Jan 7, 2021 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Nov 12, 2020 Nov 10, 2020 001-38981
4 Open Document Open Filing FORM 4 SUBMISSION Jan 14, 2020 Jan 10, 2020 001-38981
3 Open Document Open Filing FORM 3 SUBMISSION Jul 17, 2019 Jul 17, 2019 001-38981